Increased plasma 8,12-iso-iPF2alpha-VI levels in relapsing multiple sclerosis patients are not predictive of disease progression

C.E. Teunissen, M.H. Sombekke, L van Winsen, J. Killestein, F. Barkhof, C.H. Polman, C.D. Dijkstra, M.A. Blankenstein, D. Pratico

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1092-1098
JournalMultiple Sclerosis
Issue number8
Publication statusPublished - 2012

Cite this